1.
The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months 6-12.
Wall Michael, Kupersmith Mark J, Thurtell Matthew J, Moss Heather E, Moss Elizabeth Ann, Auinger Peggy
Am J OphthalmolJan 201721 citationsClinical Trial
This study found acetazolamide's visual benefits in IIH continued to 12 months, with late ACZ initiation significantly improving papilledema, headache, and quality of life.